Francisella tularensis is a zoonotic, Gram-negative coccobacillus that causes tularemia in humans and animals. F. tularensis subspecies tularensis (type A) and F. tularensis subspecies holarctica (type B) are antigenically similar and more virulent than Francisellanovicida in humans. The genetic locus that encodes the LPS O antigen was found to be substantially different between the type B live vaccine strain (LVS) and F. novicida. One LVS-specific gene with homology to a galactosyl transferase was selected for allelic replacement using a sacB–chloramphenicol expression suicide plasmid, and recombinants were screened for colony morphology on Congo red agar that matched that of F. novicida. Two mutants (WbtIS187Y and WbtIG191V) were isolated that contained substitutions in conserved motifs in the sugar transamine/perosamine synthetase (WbtI) of the O-antigen locus, and the latter mutant was extensively tested and characterized. WbtIG191V grew at the same rate as the parent strain in Chamberlain's defined medium, completely lacked O antigen, was serum-sensitive but could grow in a mouse macrophage cell line, had increased resistance to sodium deoxycholate, and was highly attenuated in mice. Complementation of WbtIG191V with the wild-type wbtI gene in trans restored normal LPS synthesis, phenotypic properties similar to the parent, and virulence in mice. Immunization with WbtIG191V protected mice against a relatively low-dose intraperitoneal challenge with LVS, but was less protective against a high-dose challenge. These results indicate that complete loss of O antigen alters the surface phenotype and abrogates virulence in F. tularensis, but also compromises the induction of full protective immunity against F. tularensis infection in mice.
BernierS. P.,
SokolP. A.2005; Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol 187:5278–5291
ChenW.,
ShenH.,
WebbA.,
KuoleeR.,
ConlanJ. W.2003; Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21:3690–3700
ChenW.,
KuoleeR.,
ShenH.,
BusaM.,
ConlanJ. W.2005; Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS. Immunol Lett 97:151–154
ColeL. E.,
ElkinsK. L.,
MichalekS. M.,
QureshiN.,
EatonL. J.,
RallabhandiP.,
CuestaN.,
VogelS. N.2006; Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J Immunol 176:6888–6899
ConlanJ. W.,
ChenW.,
ShenH.,
WebbA.,
KuoLeeR.2003; Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb Pathog 34:239–248
ConlanJ. W.,
ShenH.,
KuoleeR.,
ZhaoX.,
ChenW.2005; Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon gamma-dependent mechanism. Vaccine 23:2477–2485
CowleyS. C.,
ElkinsK. L.2003; Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon γ receptors. J Exp Med 198:379–389
DennisD. T.,
InglesbyT. V.,
HendersonD. A.,
BartlettJ. G.,
AscherM. S.,
EitzenE.,
FineA. D.,
FriedlanderA. M.,
HauerJ.other authors 2001; Tularemia as a biological weapon: medical and public health management. JAMA J Am Med Assoc 285:2763–2773
DeShazerD.,
WaagD. M.,
FritzD. L.,
WoodsD. E.2001; Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 30:253–269
HajjarA. M.,
HarveyM. D.,
ShafferS. A.,
GoodlettD. R.,
SjöstedtA,
EdebroH.,
ForsmanM.,
ByströmM.,
PelletierM.other authors2006; Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun 74:6730–6738
HarakavaR.,
GabrielD. W.2003; Genetic differences between two strains of Xylella fastidiosa revealed by suppression subtractive hybridization. Appl Environ Microbiol 69:1315–1319
HartleyG.,
TaylorR.,
PriorJ.,
NewsteadS.,
HitchenP. G.,
MorrisH. R.,
DellA.,
TitballR. W.2005; Grey variants of the live vaccine strain of Francisella tularensis lack lipopolysaccharide O-antigen, show reduced ability to survive in macrophages and do not induce protective immunity in mice. Vaccine 24:989–996
InzanaT. J.,
AndersonP.1985; Serum factor-dependent resistance of Haemophilus influenzae type b to antibody to lipopolysaccharide. J Infect Dis 151:869–877
InzanaT. J.,
GlindemannG. E.,
SniderG.,
GardnerS.,
CroftonL.,
ByrneB.,
HarperJ.2004; Characterization of a wild-type strain of Francisella tularensis isolated from a cat. J Vet Diagn Invest 16:374–381
LiJ. W.,
InoueY.,
MiyazakiM.,
PuH.,
KondoA.,
NambaM.2000; Growth inhibitory effects of ATP and its derivatives on human fibroblasts immortalized with 60Co-gamma rays. Int J Mol Med 5:59–62
LiuL.,
SpilkerT.,
CoenyeT.,
LiPumaJ. J.2003; Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol 41:2471–2476
MaierT. M.,
HavigA.,
CaseyM.,
NanoF. E.,
FrankD. W.,
ZahrtT. C.2004; Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol 70:7511–7519
MerkleR. K.,
PoppeI.1994; Carbohydrate composition analysis of glycoconjugates by gas-liquid chromatography/mass spectrometry. Methods Enzymol 230:1–15
NewtonH. J.,
SansomF. M.,
Bennett-WoodV.,
HartlandE. L.2006; Identification of Legionella pneumophila-specific genes by genomic subtractive hybridization with Legionella micdadei and identification of lpnE, a gene required for efficient host cell entry. Infect Immun 74:1683–1691
ParsonsY. N.,
BanaskoR.,
DetsikaM. G.,
DuangsonkK.,
RainbowL.,
HartC. A.,
WinstanleyC.2003; Suppression-subtractive hybridisation reveals variations in gene distribution amongst the Burkholderia cepacia complex, including the presence in some strains of a genomic island containing putative polysaccharide production genes. Arch Microbiol 179:214–223
PennR. L.2005; Francisella tularensis (tularemia). . In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases pp 2674–2685 Edited by
MandellG. L.,
BennettJ. E.,
DolinR.
Philadelphia, PA: Elsevier Churchill Livingstone;
PhillipsN. J.,
SchillingB.,
McLendonM. K.,
ApicellaM. A.,
GibsonB. W.2004; Novel modification of lipid A of Francisella tularensis. Infect Immun 72:5340–5348
PriorJ. L.,
PriorR. G.,
HitchenP. G.,
DiaperH.,
GriffinK. F.,
MorrisH. R.,
DellA.,
TitballR. W.2003; Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensissubsp. tularensis. J Med Microbiol 52:845–851
SambrookJ.,
FritschE. F.,
ManiatisT.1989Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
SandströmG.,
LöfgrenS.,
TärnvikA.
1988; A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun 56:1194–1202
ShenH.,
ChenW.,
ConlanJ. W.2004; Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22:2116–2121
SjöstedtA.
2005; Family III. Francisellaceae, fam. nov.. In Bergey's Manual of Systematic Bacteriology, 2nd edn. pp 199–210 Edited by
GarrityG.,
BrennerD. J.,
KreigN. R.,
StaleyJ. T.,
BooneD. R.,
VosP. De,
GoodfellowM.,
RaineyF. A.,
GarrityG. M.,
SchleifferK.-H.
New York: Springer;
StaplesJ. E.,
KubotaK. A.,
ChalcraftL. G.,
MeadP. S.,
PetersenJ. M.2006; Epidemiologic and molecular analysis of human tularemia, United States, 1964–2004. Emerg Infect Dis 12:1113–1118
SturialeL.,
GarozzoD.,
SilipoA.,
LanzettaR.,
ParrilliM.,
MolinaroA.2005; New conditions for matrix-assisted laser desorption/ionization mass spectrometry of native bacterial R-type lipopolysaccharides. Rapid Commun Mass Spectrom 19:1829–1834
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
TimoneyJ. F.,
GillespieJ. H.,
ScottF. W.,
BarloughJ. E.1988; The genus Francisella. In Hagan and Bruner's Microbiology and Infectious Diseases of Domestic Animals pp 132–135 Edited by
TimoneyJ. F.,
GillespieJ. H.,
ScottF. W.,
BarloughJ. E.
Ithaca, NY: Cornell University Press;
VinogradovE. V.,
ShashkovA. S.,
KnirelY. A.,
KochetkovN. K.,
TochtamyshevaN. V.,
AverinS. F.,
GoncharovaO. V.,
KhlebnikovV. S.1991; Structure of the O-antigen of Francisella tularensis strain 15. Carbohydr Res 214:289–297
VinogradovE. V.,
BockK.,
HolstO.,
BradeH.1995; The structure of the lipid A-core region of the lipopolysaccharides from Vibrio cholerae O1 smooth strain 569B (Inaba) and rough mutant strain 95R (Ogawa. Eur J Biochem 233:152–158
VinogradovE.,
ConlanW. J.,
GunnJ. S.,
PerryM. B.2004; Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112. Carbohydr Res 339:649–654
WardC. K.,
LawrenceM. L.,
VeitH. P.,
InzanaT. J.1998; Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a: concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A. pleuropneumoniae serotype 1. Infect Immun 66:3326–3336